statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Latest Ratings for IONS
 DateFirmActionFromTo Mar 2022GuggenheimInitiates Coverage OnBuy Mar 2022CitigroupInitiates Coverage OnSell Feb 2022SVB LeerinkMaintainsMarket Perform
 View More Analyst...

The Latest Analyst Ratings For Ionis Pharmaceuticals

Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome Ionis presents positive results from Phase 3 Balance study of olezarsen for familial...

Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome

DAVENPORT  Co LLC cut its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 0.6% during the fourth quarter, according to the company in its most recent disclosure with the...

DAVENPORT & Co LLC Has $4.37 Million Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Ionis Pharmaceuticals management to meet with Piper Sandler

Ionis to present at upcoming investor conferences Ionis to present at upcoming investor conferences PR Newswire CARLSBAD, Calif., April 1, 2024 CARLSBAD, Calif., April 1, 2024 /PRNewswire/ -- Ionis...

Ionis to present at upcoming investor conferences

Ionis to hold olezarsen Phase 3 data webcast Ionis to hold olezarsen Phase 3 data webcast PR Newswire CARLSBAD, Calif., March 28, 2024 Webcast scheduled for Monday, April 8 at 10:00 a.m. Eastern Time...

Ionis to hold olezarsen Phase 3 data webcast

This price move could be a signal that IONS may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Ionis Pharmaceuticals (IONS, $44.66) price may drop as it broke higher Bollinger Band on Mar 27, 2024

This is a signal that IONS's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Ionis Pharmaceuticals (IONS, $44.1) Stochastic Oscillator left the overbought zone on March 26, 2024

Ionis Pharmaceuticals to present data from Phase 3 on olezarsen

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Volume	1.14M
52-Wk High	$54.44
52-Wk Low	$34.32

IONS Ionis Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals